202 related articles for article (PubMed ID: 36737429)
1. Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics.
Ogiya D; Chyra Z; Verselis SJ; O'Keefe M; Cobb J; Abiatari I; Talluri S; Sithara AA; Hideshima T; Chu MP; Hájek R; Dorfman DM; Pilarski LM; Anderson KC; Adamia S
Blood Cancer J; 2023 Feb; 13(1):23. PubMed ID: 36737429
[TBL] [Abstract][Full Text] [Related]
2. Alteration of introns in a hyaluronan synthase 1 (HAS1) minigene convert Pre-mRNA [corrected] splicing to the aberrant pattern in multiple myeloma (MM): MM patients harbor similar changes.
Kriangkum J; Warkentin A; Belch AR; Pilarski LM
PLoS One; 2013; 8(1):e53469. PubMed ID: 23301075
[TBL] [Abstract][Full Text] [Related]
3. Read-Split-Run: an improved bioinformatics pipeline for identification of genome-wide non-canonical spliced regions using RNA-Seq data.
Bai Y; Kinne J; Donham B; Jiang F; Ding L; Hassler JR; Kaufman RJ
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):503. PubMed ID: 27556805
[TBL] [Abstract][Full Text] [Related]
4. Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genes.
Cao X; Huber S; Ahari AJ; Traube FR; Seifert M; Oakes CC; Secheyko P; Vilov S; Scheller IF; Wagner N; Yépez VA; Blombery P; Haferlach T; Heinig M; Wachutka L; Hutter S; Gagneur J
Genome Med; 2024 May; 16(1):70. PubMed ID: 38769532
[TBL] [Abstract][Full Text] [Related]
5. Splicing dysregulation in human hematologic malignancies: beyond splicing mutations.
De Kesel J; Fijalkowski I; Taylor J; Ntziachristos P
Trends Immunol; 2022 Aug; 43(8):674-686. PubMed ID: 35850914
[TBL] [Abstract][Full Text] [Related]
6. Aberrant posttranscriptional processing of hyaluronan synthase 1 in malignant transformation and tumor progression.
Adamia S; Kriangkum J; Belch AR; Pilarski LM
Adv Cancer Res; 2014; 123():67-94. PubMed ID: 25081526
[TBL] [Abstract][Full Text] [Related]
7. A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets.
Adamia S; Haibe-Kains B; Pilarski PM; Bar-Natan M; Pevzner S; Avet-Loiseau H; Lode L; Verselis S; Fox EA; Burke J; Galinsky I; Dagogo-Jack I; Wadleigh M; Steensma DP; Motyckova G; Deangelo DJ; Quackenbush J; Stone R; Griffin JD
Clin Cancer Res; 2014 Mar; 20(5):1135-45. PubMed ID: 24284058
[TBL] [Abstract][Full Text] [Related]
8. The effects of MicroRNA deregulation on pre-RNA processing network in multiple myeloma.
Adamia S; Abiatari I; Amin SB; Fulciniti M; Minvielle S; Li C; Moreau P; Avet-Loiseau H; Munshi NC; Anderson KC
Leukemia; 2020 Jan; 34(1):167-179. PubMed ID: 31182781
[TBL] [Abstract][Full Text] [Related]
9. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
10. DAZAP1 facilitates the alternative splicing of KITLG to promote multiple myeloma cell proliferation via ERK signaling pathway.
Zhou Y; Huangfu S; Li M; Tang C; Qian J; Guo M; Zhou Z; Yang Y; Gu C
Aging (Albany NY); 2022 Oct; 14(19):7972-7985. PubMed ID: 36242590
[TBL] [Abstract][Full Text] [Related]
11. Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens.
Liao W; Jordaan G; Nham P; Phan RT; Pelegrini M; Sharma S
BMC Cancer; 2015 Oct; 15():714. PubMed ID: 26474785
[TBL] [Abstract][Full Text] [Related]
12. Alternative RNA splicing defects in pediatric cancers: new insights in tumorigenesis and potential therapeutic vulnerabilities.
Venkataramany AS; Schieffer KM; Lee K; Cottrell CE; Wang PY; Mardis ER; Cripe TP; Chandler DS
Ann Oncol; 2022 Jun; 33(6):578-592. PubMed ID: 35339647
[TBL] [Abstract][Full Text] [Related]
13. [Aberrant RNA splicing and development of hematological malignancies].
Yoshimi A
Rinsho Ketsueki; 2020; 61(6):634-642. PubMed ID: 32624537
[TBL] [Abstract][Full Text] [Related]
14. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.
Scott LM; Rebel VI
J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622
[TBL] [Abstract][Full Text] [Related]
15. Alternative pre-mRNA splicing in digestive tract malignancy.
Miura K; Fujibuchi W; Sasaki I
Cancer Sci; 2011 Feb; 102(2):309-16. PubMed ID: 21134075
[TBL] [Abstract][Full Text] [Related]
16. Differential RNA splicing as a potentially important driver mechanism in multiple myeloma.
Bauer MA; Ashby C; Wardell C; Boyle EM; Ortiz M; Flynt E; Thakurta A; Morgan G; Walker BA
Haematologica; 2021 Mar; 106(3):736-745. PubMed ID: 32079689
[TBL] [Abstract][Full Text] [Related]
17. A case of cervical cancer expressed three mRNA variant of Hyaluronan-mediated motility receptor.
Villegas-Ruíz V; Salcedo M; Zentella-Dehesa A; de Oca EV; Román-Basaure E; Mantilla-Morales A; Dávila-Borja VM; Juárez-Méndez S
Int J Clin Exp Pathol; 2014; 7(5):2256-64. PubMed ID: 24966934
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the aberrant splicing of MAP3K7 induced by cancer-associated SF3B1 mutation.
Li Z; Zhao B; Shi Y; Liang Y; Qian R; Wan Y
J Biochem; 2021 Sep; 170(1):69-77. PubMed ID: 33751071
[TBL] [Abstract][Full Text] [Related]
19. Mutations of RNA splicing factors in hematological malignancies.
Shukla GC; Singh J
Cancer Lett; 2017 Nov; 409():1-8. PubMed ID: 28888996
[TBL] [Abstract][Full Text] [Related]
20. RNA Splicing Alterations Induce a Cellular Stress Response Associated with Poor Prognosis in Acute Myeloid Leukemia.
Anande G; Deshpande NP; Mareschal S; Batcha AMN; Hampton HR; Herold T; Lehmann S; Wilkins MR; Wong JWH; Unnikrishnan A; Pimanda JE
Clin Cancer Res; 2020 Jul; 26(14):3597-3607. PubMed ID: 32122925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
